We have isolated a new mouse gene, odd-skipped related 2 (Osr2), that encodes a zinc ®nger containing protein related to Drosophila Odd-skipped. The putative OSR2 protein shares 65% amino acid sequence identity overall and 98% sequence identity in the zinc ®nger region, respectively, with the previously reported Osr1 gene product. During mouse embryonic development, Osr2 expression is ®rst detected at E9.25, speci®cally in the mesonephric vesicles. By E10.0, Osr2 expression is also observed in the rostro-lateral mandibular mesenchyme immediately adjacent to the maxillary processes. In the developing limb buds, Osr2 is expressed in a unique mesenchymal domain and the onset of Osr2 expression follows a distinct dorsal to ventral developmental time sequence beginning in the forelimb and then in the hindlimb. Osr2 exhibits a dynamic expression pattern during craniofacial development, in the mandibular and maxillary processes as well as the developing palate. Osr2 is also expressed at sites of epithelial-mesenchymal interactions during tooth and kidney development. q
Results
The Drosophila pair-rule gene odd-skipped and two related genes, bowel and sob, encode a sub-family of zinc ®nger containing transcription factors essential for embryonic development and patterning (Nusslein-Volhard and Wieschaus, 1980; DiNardo and O'Farrell, 1997; Coulter and Wieschaus, 1988; Coulter et al., 1990; Mullen and DiNardo, 1995; Wang and Coulter, 1996; Hart et al., 1996; Saulier-Le Drean et al., 1998) . One mouse gene, odd-skipped related 1 (Osr1), encoding a zinc ®nger protein with signi®cant amino acid sequence identity to the Oddskipped family, has been reported (So and Danielian, 1999) . Here we report the isolation and characterization of a new mouse odd-skipped related gene, Osr2. We isolated two near full-length mouse cDNAs (see Section 2) that encode the same protein of 276 amino acid residues containing three Odd-skipped type C2H2 zinc ®nger domains (Fig.  1) . The putative OSR2 protein shares 65% sequence identity overall and 98% sequence identity in the zinc ®nger region, respectively, with OSR1. Southern hybridization analyses indicate that Osr2 is a single copy gene distinct from Osr1 (data not shown).
We have analyzed the expression pattern of Osr2 during mouse development by whole mount in situ hybridization and compared that with the expression pattern of Osr1. In contrast to Osr1, which is expressed in intermediate mesoderm as early as E8.0 (So and Danielian, 1999) , Osr2 expression is not detected in the early developing embryos until E9.25 (about 18 somites) when it is ®rst detected speci®cally in the mesonephros ( Fig. 2A,B) . The levels of Osr2 mRNA in the mesonephros increase from E9.25 to E10.0. By E10.0, Osr2 expression is also observed in the rostrolateral region of the mandibular mesenchyme as well as in a sharply demarcated central region of the dorsal forelimb mesenchyme (Fig. 2C±F) . The onset of Osr2 expression in the developing limb buds follows a dorsal to ventral sequence in the forelimb and then in the hindlimb from E10.0 to E11.0 (Fig. 1E±I,M) . Whereas the expression domain of Osr2 in the mandibular mesenchyme appears to overlap with that of Osr1, these two genes are expressed in (Fig. 2 , compare I with J). In addition, Osr2 is not expressed in the developing somites, in contrast to Osr1. At E10.5, Osr2 expression is observed in two stripes of cells at the oral side of the maxillary processes corresponding to where the bilateral palatal processes initiate (Fig. 2K ). By E11.5, Osr2 expression is detected in the medial nasal processes and distal maxillary processes, whereas Osr1 expression is detected in the distal mandibular processes (Fig. 2N ,O). Osr2 is also expressed in tissues surrounding the developing eye, with stronger expression in the posterior and ventral regions ( Fig. 2M,P) .
We analyzed Osr2 expression further in internal embryonic structures using in situ hybridization on paraf®n sections. With the exception of the regions surrounding the developing eye, where Osr2 expression is detected in the mesenchyme as well as epithelia (Fig. 3B,D) , Osr2 expression is restricted to speci®c mesenchymal tissues, including the mesenchyme in the developing palatal shelves, the tongue, and the mesenchyme surrounding the esophagus and the developing thyroid gland (Fig. 3A,D) . At E14.5, Osr2 is strongly expressed in the mesenchymal cells surrounding the tooth buds (Fig. 3D ) and in the mesenchymal cells surrounding epithelial ducts in the mesonephros (Fig. 3E) . Osr2 is also expressed in a subset of mesenchymal cells adjacent to the epithelial tubules in the developing metanephros (Fig. 3F) . In these tissues, Osr2 expression correlates with sites of epithelial-mesenchymal interactions.
Materials and methods

Isolation of OSR2
Searching the human genome sequences with the mouse OSR1 protein sequence identi®ed two potentially related human genes. One (Genbank accession number AC016391) apparently encodes a protein homologous to OSR1, the other (Genbank accession number AC016877) shows a similar genomic structure and encodes a similar but distinct protein. We refer to the latter gene as putative human OSR2. These two genes are located on different chromosomes. Using PCR primers (ATCGTCGACATG-GGGAGCAAGGCTCTGCC and CTGGGATCCCGCAG-GTGATCTTGCC) corresponding to sequences within the ®rst coding exon of the putative human OSR2 gene, we ampli®ed a mouse DNA fragment of expected size from E11.5 mouse cDNA. Using the sequence of the PCR product, we searched the mouse expressed sequence tags database (dbest) and obtained two matched mouse EST clones (IMAGE clone ID 4011043 and 699627) from different cDNA libraries. We then sequenced both cDNA clones and found that they are of similar size (1.7 Kb) and consist of nearly identical sequences with identical open reading frames and polyadenylation signals. The only differences between these two cDNA sequences were three single nucleotide polymorphisms that do not change the encoded Fig. 1 . Comparison of the mouse OSR2 and OSR1 protein sequences. The nucleotide sequence of the 1725 bp Osr2 cDNA has been submitted to Genbank (accession number AF370121). Deduced amino acid sequences of OSR2 and OSR1 (So and Danielian, 1999) were compared. Identical amino acid residues are highlighted. E10 .5, the hindlimb buds (hl) start to express Osr2 in the dorsal mesenchyme (arrow); (I,J) lateral views of E10.5 whole mount embryos showing distinct expression patterns for Osr2 (I) and Osr1 (J) in the maxillary (mx) and mandibular (mb) processes, the second branial arch (b2), fore-(¯) and hindlimb (hl) buds, and somites (s); (K,L) ventral views of the E10.5 embryonic heads showing that Osr2 (K), but not Osr1 (L), is expressed in the secondary palate primodia (arrow); (M) at E11.0, Osr2 expression domain in the mandibular (mb) mesenchyme extends into the maxillary (mx) mesenchyme. The ventral side of the hindlimb (arrow) and regions surrounding the developing eye (e) also start to express Osr2; (N,O) Ventral views of E11.0 embryonic heads showing differential expression of Osr2 and Osr1, with Osr2 expression in the maxillary and medial nasal processes (arrows in N) and Osr1 in the distal mandibular processes (arrowheads in O); (P) at E12.0, strong Osr2 expression persists in speci®c regions of the maxillary and mandibular processes, the fore-and hind-limbs, and in regions surrounding the developing eye. Osr2 expression is also observed in the pharyngeal pouches in between the second (b2) and third (b3) branchial arches and posterior to the third branchial arches. Scale bar, 50 mm. amino acid residues. A probe containing the 5 H region of the Osr2 cDNA hybridized to a single band at about 1.8 Kb on a mouse embryonic RNA blot (Clontech), indicating that the two cDNA clones we obtained are near full-length. Sequence analyses were performed using MacVector (Oxford Molecular Ltd.).
In situ hybridization
In situ hybridization of whole mount and sectioned embryos was carried out as previously described (Jiang et al., 1998; McGrath et al., 1999) . Digoxygenin-and 33 Plabeled antisense RNA probes were made using a subcloned 650 bp fragment containing sequences 5 H to the zinc ®nger coding region of the Osr2 cDNA. Fig. 3 . Expression patterns of Osr2 mRNA in the craniofacial region and the developing meso-and metanephros. (A,B) Sagittal (A) and frontal (B) sections of E12.5 mouse embryos hybridized with an antisense Osr2 riboprobe. Strong Osr2 mRNA signals are detected in the mesenchyme of the primary palate and mandibular processes, the secondary palate, the developing tongue, and mesenchyme surrounding the olfatory epithlium and the esophagus. Osr2 is also highly expressed in the mesenchme surrounding the developing eye. No Osr2 expression is detected in the central nervous system at all embryonic stages examined. (C,D) Sagittal (C) and frontal (D) sections of E14.5 mouse embryos hybridized with an antisense Osr2 riboprobe. Osr2 expression in the palatal shelves and tongue decreases by E14.5. Intense Osr2 expression is observed in the mesenchyme condensing around developing thyroid gland and the ®rst molar tooth buds. In regions around the developing eye, Osr2 is expressed in the eyelid and corneal epithelia as well as in the mesenchyme around the optic cup. (E,F) Strong Osr2 expression is also observed in the mesenchyme surrounding the epithelial ducts in the mesonephros (E) and metanephros (F). de, dental epithelium; e, eye; es, esophagus; mb, mandibular process; md, mesonephric duct; oe, olfactory epithelium; p, secondary palate; pp, primary palate; t, tongue; th, thyroid gland. Scale bar is 500 mm in all except (E) in which the scare bar is 100 mm.
